Alimera Sciences Inc
ALIMDelisted Sep 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267602
Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Alimera Sciences Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ALIM is no longer listed, and 13F filings after Q2 2024 list far fewer holders. See Q2 2024
- Institutional holders
- 0
- −51 vs. Q2 2024
- Shares held
- 0
- −45.0M (−100.0%) vs. Q2 2024
- Total value
- $0
- −$250.2M (−100.0%) vs. Q2 2024
- New holders
- 0
- 0 more added
- Sold out
- 51
- 0 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 52 | $257.9M |
| Q1 2024 | 39 | $186.9M |
| Q4 2023 | 35 | $208.4M |
| Q3 2023 | 30 | $146.5M |
| Q2 2023 | 18 | $10.3M |
| Q1 2023 | 16 | $4.30M |
| Q4 2022 | 20 | $6.13M |
| Q3 2022 | 14 | $8.73M |
| Q2 2022 | 20 | $9.00M |
| Q1 2022 | 18 | $8.49M |
| Q4 2021 | 21 | $9.09M |
| Q3 2021 | 27 | $8.29M |
| Q2 2021 | 25 | $17.9M |
| Q1 2021 | 25 | $18.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Alimera Sciences Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caligan Partners LP | 0 | $0 | 0.00% | −16,835,154−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −13,608,533−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −3,511,816−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −3,198,708−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −2,150,000−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −1,177,745−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,003,617−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −638,396−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −551,533−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −515,304−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −374,531−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −181,694−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −139,100−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −124,169−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −108,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −97,741−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −86,299−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −62,284−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −61,907−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −60,650−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −39,300−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −50,431−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −37,886−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −28,920−100.0% | Sold out |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −25,930−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −22,791−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −20,850−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −20,394−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −18,100−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −17,848−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −17,800−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,895−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −14,502−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −11,526−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,873−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,266−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,061−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −7,157−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,679−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −2,298−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,099−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2,015−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −1,552−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −741−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −694−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −666−100.0% | Sold out |
| Syntax Research, Inc. | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |